| MolName | [2-(1,3-benzothiazol-2-ylamino)-2-oxoethyl] (E)-3-[4-(3-sulfamoylanilino)phenyl]prop-2-enoate |
| MolecularFormula | C24H20N4O5S2 |
| Smiles | NS(c1cc(Nc2ccc(/C=C/C(OCC(Nc3nc(cccc4)c4s3)=O)=O)cc2)ccc1)(=O)=O |
| InChI | InChI=1S/C24H20N4O5S2/c25-35(31,32)19-5-3-4-18(14-19)26-17-11-8-16(9-12-17)10-13-23(30)33-15-22(29)28-24-27-20-6-1-2-7-21(20)34-24/h1-14,26H,15H2,(H2,25,31,32)(H,27,28,29) |
| InChIK | AXOILMKCVINFLR-UHFFFAOYSA-N |
| TotalMolweight | 508.578 |
| Molweight | 508.578 |
| MonoisotopicMass | 508.087511 |
| CLogP | 3.791 |
| CLogS | -5.845 |
| H Acceptors | 9 |
| H Donors | 3 |
| TotalSurfaceArea | 367.86 |
| Relative PSA | 0.36476 |
| PolarSurfaceArea | 177.1 |
| Druglikeness | -3.4902 |
| Mutagenic | high |
| Tumorigenic | low |
| Reproductive Effective | none |
| Irritant | high |
| Nasty Functions | |
| Shape Index | 0.62857 |
| Fragments | 1 |
| Non HAtoms | 35 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| Rotatable Bond | 9 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 21 |
| Sp3Atoms | 3 |
| Symmetricatoms | 3 |
| Amides | 2 |
| Amines | 1 |
| Aromatic Amines | 1 |
| Aromatic Nitrogens | 1 |
| StereoCon |
Click to Load Molecule:
1 - [2-(1,3-benzothiazol-2-ylamino)-2-oxoethyl] (E)-3-[4-(3-sulfamoylanilino)phenyl]prop-2-enoate | 2 - [2-(1,3-benzothiazol-2-ylamino)-2-oxoethyl] (E)-3-[4-(3-sulfamoylanilino)phenyl]prop-2-enoate